Antibiotice posted RON 10.9m net profit in 2Q07 (down 0.2% q/q and up 83.4% y/y), 51.6% above our expectation of RON 7.2m, due to higher-than expected operating revenues and lower-than expected operating expenses. We expect a positive trading impact on the result due to a sharp improvement in both EBIT and net margins.